United States
Germany
Japan
United Kingdom
China
KIR2DL2 Antibody - C-terminal region
| Applications | WB |
| Reactivities | Human |
Antibodies
Anti-KIR2DL2(lirilumab biosimilar) mAb
| Applications | FC |
| Reactivities | Human |
KIR2DL2 Antibody - C-terminal region
| Applications | WB |
| Reactivities | Human |
Anti-KIR2DL2(lirilumab biosimilar) mAb
| Applications | FC |
| Reactivities | Human |
